Calcitonin gene‐related peptide‐targeting therapies are a first‐line option for the prevention of migraine: An American Headache Society position statement update

Documenti analoghi

• Routine migraine screening as a standard of care for Women's health: A position statement from the American Headache Society
  di: Todd J. Schwedt, et al.
  Pubblicazione: (2025)
• The cortical spreading depression/migraine aura hypothesis – Finally some definitive evidence
  di: Andrew C. Charles, et al.
  Pubblicazione: (2025)
• A critical appraisal of the International Classification of Headache Disorders migraine diagnostic criteria based on a retrospective multicenter cross‐sectional headache registry study in youth
  di: Carlyn Patterson Gentile, et al.
  Pubblicazione: (2024)
• Navigating the patient journey in migraine prevention: An American Migraine Foundation position paper
  di: Lawrence C. Newman, et al.
  Pubblicazione: (2025)
• Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies
  di: Irina Krikova, et al.
  Pubblicazione: (2024)